Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
SHARES in Samsung's drug-making unit soared almost six per cent on their market debut on Thursday, after one of South Korea's biggest ever initial public offerings that raised nearly US$2 billion.
Samsung Biologics, a contract manufacturer of biotech drugs for global